|
|
Volumn 53, Issue 3, 2004, Pages 135-138
|
|
A primer on cancer immunology and immunotherapy
|
|
Author keywords
Immunotherapy; Primer; Tumor immunology
|
|
Indexed keywords
ALPHA INTERFERON;
ANTIBODY;
CANCER VACCINE;
CD40 ANTIBODY;
CD40 LIGAND;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FC RECEPTOR;
FLT3 LIGAND;
HLA ANTIGEN CLASS 1;
HLA DR ANTIGEN;
HYBRID PROTEIN;
INTERLEUKIN 12;
INTERLEUKIN 15;
INTERLEUKIN 18;
INTERLEUKIN 2;
MELANOMA ANTIGEN;
PEPTIDE;
SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VIRUS VECTOR;
ADOPTIVE TRANSFER;
ANTINEOPLASTIC ACTIVITY;
BREAST CARCINOGENESIS;
CANCER IMMUNOLOGY;
CANCER IMMUNOTHERAPY;
CANCER INHIBITION;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CLONAL ANERGY;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
EFFECTOR CELL;
GENE FUNCTION;
GENETIC STABILITY;
HUMAN;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
IMMUNOLOGICAL TOLERANCE;
IMMUNOREGULATION;
INFLAMMATION;
MELANOMA;
MOLECULAR RECOGNITION;
NATURAL KILLER CELL;
NONHUMAN;
ONCOGENE NEU;
PRIORITY JOURNAL;
REVIEW;
TUMOR CELL;
TUMOR CELL DESTRUCTION;
TUMOR IMMUNITY;
TUMOR XENOGRAFT;
ANTIGENS, NEOPLASM;
DENDRITIC CELLS;
HUMANS;
IMMUNOTHERAPY;
KILLER CELLS, NATURAL;
NEOPLASMS;
T-LYMPHOCYTES, CYTOTOXIC;
|
|
EID: 1542297657
PISSN: 03407004
EISSN: None
Source Type: Journal
DOI: 10.1007/s00262-003-0467-7 Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|
